1-3 of 3
Divy Kangeyan
Close
Sort by
Journal Articles

Efficient and Specific Multi-Locus Editing of Allogeneic CAR T Cells for Hypoimmunity during Large Scale Manufacture Using Cas12b

Christina Chaivorapol, Pascal Beauchesne, Rowena De Jesus, William E Dowdle, Xiaoyu Chen, Alison Bayley, Yunjiang Qiu, Andrew Birnberg, Yu Zheng, Antonino Montalbano, Angela Liu, Misbah Zafar, Karl Manner, Ramya Ankala, Eleonore Tham, Heer Shah, Ben Lam, Jaclyn Lock, Lindong Weng, Kate Watts, Amanda Valdiosera, Kimberly Davis, Lei Wang, Divy Kangeyan, PhD, Nicolas Devos, Athena Wong, Jason Lih, Edward J Rebar
Journal: Blood
Blood (2022) 140 (Supplement 1): 1606–1607.
https://doi.org/10.1182/blood-2022-167627
Published: 2022
Journal Articles

Functional T Cell Assays Are Predictive of Pre-Clinical Potency to Generate Allogeneic, Hypoimmune CD19 CAR T Cells

Darin Salloum, PhD, Kavita Tundwal, Divy Kangeyan, PhD, Adam Johnson, Neal van Hoeven, PhD, Brian Granger, Jesus Moreno, Ouwen Liang, Pascal Beauchesne, Terry J. Fry, Aaron Foster
Journal: Blood
Blood (2022) 140 (Supplement 1): 4524–4525.
https://doi.org/10.1182/blood-2022-168372
Published: 2022
Journal Articles

Single Cell Bisulfite Sequencing Defines Epigenetic Diversification in Chronic Lymphocytic Leukemia

Dan A. Landau, MD PhD, Kendell Clement, Hongcang Gu, Evan Biederstedt, MA, Divy Kangeyan, Steven Hill, Lili Wang, MD PhD, Martin Aryee, PhD, Andreas Gnirke, Alex Meissner, Catherine J Wu, MD
Journal: Blood
Blood (2016) 128 (22): 1047.
https://doi.org/10.1182/blood.V128.22.1047.1047
Published: 2016